Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: Netherlands Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20051
20062
20086
20091
20101
20151
20161
20181
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
European Organisation for Research and Treatment of Cancer - EORTC3
Hoffmann-La Roche3
Bayer2
Children's Oncology Group1
Cristal Therapeutics1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1
Fore Biotherapeutics1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms21
Neoplasms4
Breast Neoplasms3
Cholangiocarcinoma3
Urinary Bladder Neoplasms3
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Esophageal Neoplasms2
Fallopian Tube Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.